Review the methodology and clinical utility of polyethylene glycol-enhanced thyroid-stimulating antibody assays for diagnosing and managing Graves' disease.
Evaluated TSAb utility in diagnosing hyperthyroidism and guiding clinical management in Graves' disease.
Polyethylene glycol-assisted assays improve the sensitivity and reliability of TSAb detection in serum.
TSAb levels provide a crucial diagnostic biomarker and functional index for monitoring therapeutic response and disease remission in Graves' disease.
Abstract
Thyroid stimulating antibody (TSAb) causes hyperthyroidism of Graves' disease. TSAb has been used as the diagnosis for Graves' disease and also in the index of clinical management of Graves' patien...